Literature DB >> 17080296

Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizli province of Turkey.

Sebahat Turgut1, Günfer Turgut, Erol Omer Atalay.   

Abstract

Human p-glycoprotein encoded by human multidrug resistance (MDR1) gene, is a transmembrane protein that serves as efflux pump for a wide variety of lipophilic compounds possessing a physiological role in protecting cells against the DNA damaging of certain xenobiotics. According to the published data, the frequency of C3435T polymorphism differs depending on the different ethnical populations such as Asian, African, and Caucasians populations. In our study, we identified the MDR1 C3435T polymorphism in 150 healthy volunteers in Denizli province of Turkey. DNA was extracted from peripheral blood samples by standard phenol/chloroform extraction method. Polymerase chain reaction-restriction fragment length polymorphism was used for the detection of C3435T single nucleotide polymorphism. We obtained CC, CT and TT genotype frequencies as 20, 53 and 27%, respectively. According to our results, the C allele in Turkish population (Denizli province, west of Turkey) is found 47% and this data shows similarity with Caucasian (UK and German) populations and significantly lower than African populations (p < 0.001). Our study is the first data on the genotype and allele frequency of the human multidrug resistance (MDR1) Gene C3435T Polymorphism in Denizli Province at regional basis in Turkey. Our results could serve as a basis for large-scale correlation studies on the relevance of C3435T genotype in cancer therapy and other diseases in Turkish population. Investigation of genotype frequencies related with p-glycoprotein substrates should be investigated in large scale at regional bases in Turkish population. The scaled-up data might help either to the use of p-glycoprotein substrates to be used for therapeutic applications and population genetics considering the genotype frequencies possibly occurring throughout the history in Anatolian basin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080296     DOI: 10.1007/s11033-006-9022-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  35 in total

Review 1.  P-glycoprotein and multidrug resistance.

Authors:  M M Gottesman; I Pastan; S V Ambudkar
Journal:  Curr Opin Genet Dev       Date:  1996-10       Impact factor: 5.578

Review 2.  Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency.

Authors:  M W Linder; R A Prough; R Valdes
Journal:  Clin Chem       Date:  1997-02       Impact factor: 8.327

3.  The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels.

Authors:  R Kerb; A S Aynacioglu; J Brockmöller; R Schlagenhaufer; S Bauer; T Szekeres; A Hamwi; M Fritzer-Szekeres; C Baumgartner; H Z Ongen; P Güzelbey; I Roots; U Brinkmann
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

4.  Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes.

Authors:  M Poncz; D Solowiejczyk; B Harpel; Y Mory; E Schwartz; S Surrey
Journal:  Hemoglobin       Date:  1982       Impact factor: 0.849

5.  MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.

Authors:  M M Ameyaw; F Regateiro; T Li; X Liu; M Tariq; A Mobarek; N Thornton; G O Folayan; J Githang'a; A Indalo; D Ofori-Adjei; D A Price-Evans; H L McLeod
Journal:  Pharmacogenetics       Date:  2001-04

6.  Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.

Authors:  J Molnár; D Szabo; Y Mándi; I Mucsi; J Fischer; A Varga; S König; N Motohashi
Journal:  Anticancer Res       Date:  1998 Jul-Aug       Impact factor: 2.480

7.  Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody.

Authors:  Liat Binyamin; Yehuda G Assaraf; Maya Haus-Cohen; Michal Stark; Yoram Reiter
Journal:  Int J Cancer       Date:  2004-07-20       Impact factor: 7.396

Review 8.  The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.

Authors:  Paul Workman
Journal:  Cancer Chemother Pharmacol       Date:  2003-06-18       Impact factor: 3.333

Review 9.  The human genome project and the discovery of genetic determinants of cancer susceptibility.

Authors:  R Taramelli; F Acquati
Journal:  Eur J Cancer       Date:  2004-11       Impact factor: 9.162

10.  Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.

Authors:  C J Chen; D Clark; K Ueda; I Pastan; M M Gottesman; I B Roninson
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

View more
  6 in total

1.  MDR-1 gene C/T polymorphism in COPD: data from Aegean part of Turkey.

Authors:  Umran Toru; Ceylan Ayada; Osman Genç; Sebahat Turgut; Günfer Turgut; Ismet Bulut
Journal:  Int J Clin Exp Med       Date:  2014-10-15

2.  Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards.

Authors:  J Vicente; Blanca Sinues; A Fanlo; P Vasquez; J C Medina; B Martinez-Jarreta
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

3.  Association of MDR1 C3435T polymorphism with bipolar disorder in patients treated with valproic acid.

Authors:  Gunfer Turgut; Erhan Kurt; Cem Sengul; Gazi Alatas; Raziye Kursunluoglu; Timucin Oral; Sabahat Turgut; Hasan Herken
Journal:  Mol Biol Rep       Date:  2007-12-30       Impact factor: 2.316

4.  P-glycoprotein polymorphism in hypo- and hyper-thyroidism patients.

Authors:  Günfer Turgut; Mehmet Baştemir; Sebahat Turgut; Fulya Akin; Raziye Kursunluoglu; Bünyamin Kaptanoğlu
Journal:  Mol Biol Rep       Date:  2007-09-21       Impact factor: 2.316

5.  ABCB1 single nucleotide polymorphisms in the Brazilian population.

Authors:  Marcos Antonio Mauricio Scheiner; Arthur Motta Damasceno; Raquel Ciuvalschi Maia
Journal:  Mol Biol Rep       Date:  2009-05-13       Impact factor: 2.316

6.  Evaluation of multidrug resistance-1 gene C>T polymorphism frequency in patients with asthma.

Authors:  Ümran Toru; Ceylan Ayada; Osman Genç; Zehra Yaşar; Server Şahin; Emre Taşkın; İsmet Bulut; Murat Acat
Journal:  Clinics (Sao Paulo)       Date:  2015-10       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.